World's Best Scientists 2026 revealed!
Berten Ceulemans

Berten Ceulemans

D-Index & Metrics

Neuroscience

D-Index
63
Citations
12981
World Ranking
3409
National Ranking
36

Berten Ceulemans publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Berten Ceulemans sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 261 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Berten Ceulemans D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Berten Ceulemans sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 63 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Berten Ceulemans is affiliated with the University of Antwerp in Belgium, where they conduct research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Psychiatry and Mental Health, Genetics, Pediatrics, Perinatology and Child Health, Molecular Biology, and Cellular and Molecular Neuroscience.

Their research focuses extensively on topics such as epilepsy research and treatment, genetics and neurodevelopmental disorders, pharmacological effects and toxicity studies, genomics and rare diseases, neonatal and fetal brain pathology, neuroscience and neuropharmacology research, and ion channel regulation and function.

Ceulemans has contributed to numerous recent publications, including:

  • Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome (2022, JAMA Neurology)
  • KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum (2021, Brain)
  • Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome (2021, Seizure)
  • Development and Validation of a Prediction Model for Early Diagnosis of SCN1A -Related Epilepsies (2022, Neurology)
  • Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders (2020, Brain)

Their frequent co-authors include Sarah Weckhuysen, An-Sofie Schoonjans, Rima Nabbout, Renzo Guerrini, and António Gil-Nagel.

Berten Ceulemans has published predominantly in the following venues:

  • Epilepsia
  • Neurology
  • Gait & Posture
  • Neuropediatrics
  • Brain

Best Publications

  • De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

    Lieve Claes;Jurgen Del-Favero;Berten Ceulemans;Lieven Lagae

  • KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

    Sarah Weckhuysen;Simone Mandelstam;Arvid Suls;Dominique Audenaert;Dominique Audenaert

  • Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

    Markus Wolff;Katrine M Johannesen;Ulrike B S Hedrich;Silvia Masnada

  • Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

    L Lagae;J Sullivan;K Knupp;L Laux

  • Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1.

    Arvid Suls;Saul A. Mullen;Yvonne G. Weber;Kristien Verhaert

  • Successful use of fenfluramine as an add-on treatment for Dravet syndrome

    Berten Ceulemans;Marc Boel;Katrien Leyssens;Carolin Van Rossem

  • De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy

    Lieve Claes;Berten Ceulemans;Dominique Audenaert;Katrien Smets

  • Extending the KCNQ2 encephalopathy spectrum Clinical and neuroimaging findings in 17 patients

    S Weckhuysen;Ivanovic;R Hendrickx;Van, Coster, R

  • Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome

    Nathalie Van der Aa;Liesbeth Rooms;Geert Vandeweyer;Jenneke van den Ende

  • A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy

    D. Audenaert;L. Claes;B. Ceulemans;A. Löfgren

  • REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.

    Christian Beetz;Rebecca Schüle;Tine Deconinck;Khanh Nhat Tran-Viet

  • Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.

    Rima Nabbout;Elena Belousova;Mirjana P. Benedik;Tom Carter

  • Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study.

    Veerle De Herdt;Paul Boon;Berten Ceulemans;Henri Hauman

  • Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations

    Liesbet Deprez;Sarah Weckhuysen;Philip Holmgren;Arvid Suls

  • Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy

    Berten P.G.M Ceulemans;Lieve R.F Claes;Lieven G Lagae

  • Genetic spectrum of hereditary neuropathies with onset in the first year of life

    Jonathan Baets;Tine Deconinck;Els De Vriendt;Magdalena Zimoń

  • TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study

    Petrus J de Vries;Elena Belousova;Mirjana P Benedik;Tom Carter

  • Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine.

    Berten Ceulemans;An‐Sofie Schoonjans;Fabienne Marchau;Bernard P. Paelinck

  • Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients†

    Arvid Suls;Kristl G. Claeys;Dirk Goossens;Boris Harding

  • Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

    Unknown

  • Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA).

    Liesbeth Rooms;Edwin Reyniers;Rob van Luijk;Stefaan Scheers

  • Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine

    Yifan Zhang;Angéla Kecskés;Daniëlle Copmans;Mélanie Langlois

Frequent Co-Authors

Lieven Lagae
Lieven Lagae KU Leuven
Sarah Weckhuysen
Sarah Weckhuysen University of Antwerp
Peter De Jonghe
Peter De Jonghe University of Antwerp
Christel Depienne
Christel Depienne Essen University Hospital
R. Frank Kooy
R. Frank Kooy University of Antwerp
Rikke S. Møller
Rikke S. Møller University of Southern Denmark
Paul Boon
Paul Boon Ghent University
Ingo Helbig
Ingo Helbig Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in neuroscience often opens doors to various interdisciplinary career pathways. Many students find that related fields—such as psychology, social work, and family therapy—offer flexible and impactful professional options. For those interested in helping individuals and families, the masters in marriage and family therapy online is an accessible way to gain specialized skills while working or managing personal obligations.

Additionally, earning an online psychology masters can enhance career opportunities in clinical or research environments. Affordability is a key concern for many students, and it's important to research the average psychology degree cost before applying to programs. Social work is another promising avenue; for those seeking flexible entry requirements, there are several msw programs that are easier to get into and can lead to meaningful careers in community, healthcare, or education settings.

Exploring these online pathways can help neuroscience graduates diversify their skill set and access a broader range of career opportunities.

Best Scientists Citing Berten Ceulemans

Trending Scientists

Recently Published Articles